Published on Tuesday November 05, 2024

Smooth Drug Development October 2024 News Release

Monthly News – October 2024

We are pleased to share the latest updates from Smooth Drug Development for October 2024. 

New Projects

We continue to expand our portfolio with exciting new opportunities:

Full-Service Clinical Trial:

  • Finalizing a comprehensive service agreement for a Phase III trial in gynecology.
Medical Writing Services:
  • Signing a contract for a bioequivalence study with Semaglutide.

Clinical and Scientific Departments News:

  • Nimesulide Trial: Enrollment successfully completed.
  • Bempedoic Acid Trials: Two new trials were initiated.
  • Oncology BE Study: Enrollment of 42 subjects achieved.
  • Pembrolizumab Trial: Enrollment reached 20 patients.

These achievements demonstrate our commitment to advancing research and providing high-quality clinical trial services.

Business Development News:

This month, our Business Development team actively participated in key industry events and initiatives:

  • Attended the BIOPROM Forum in Europe.
  • Attended the CPHI in Italy.
  • On 11 November 2024, our Business Development Director met with Clinical Research Malaysia (CRM) to explore thriving clinical research initiatives in Malaysia.